KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Total Current Liabilities (2017 - 2025)

Guardant Health (GH) has disclosed Total Current Liabilities for 9 consecutive years, with $302.7 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 34.2% to $302.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $302.7 million through Dec 2025, up 34.2% year-over-year, with the annual reading at $302.7 million for FY2025, 34.2% up from the prior year.
  • Total Current Liabilities hit $302.7 million in Q4 2025 for Guardant Health, up from $236.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $302.7 million in Q4 2025 to a low of $95.5 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $197.0 million across 5 years, with a median of $202.9 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 191.41% in 2021 and later decreased 12.97% in 2024.
  • Year by year, Total Current Liabilities stood at $194.7 million in 2021, then fell by 0.75% to $193.2 million in 2022, then rose by 6.57% to $205.9 million in 2023, then grew by 9.55% to $225.6 million in 2024, then skyrocketed by 34.2% to $302.7 million in 2025.
  • Business Quant data shows Total Current Liabilities for GH at $302.7 million in Q4 2025, $236.9 million in Q3 2025, and $238.4 million in Q2 2025.